Selected article for: "Hubei province and respiratory illness"

Author: Sandra De Meyer; Denisa Bojkova; Jindrich Cinati; Ellen Van Damme; Christophe Buyck; Marnix Van Loock; Brian Woodfall; Sandra Ciesek
Title: Lack of Antiviral Activity of Darunavir against SARS-CoV-2
  • Document date: 2020_4_8
  • ID: 679qfp2s_1
    Snippet: In December 2019, the severe acute respiratory syndrome-associated coronavirus disease-2 2019 (SARS-CoV-2; COVID-19) emerged in Wuhan, Hubei Province, China (1) . The virus was subsequently identified as a coronavirus (CoV), in addition to SARS-CoV-1 and Middle East respiratory syndrome CoV (MERS-CoV) that passed from animals to humans where it can cause severe respiratory illness (2) . As of March 2020, COVID-19 has spread around the world with .....
    Document: In December 2019, the severe acute respiratory syndrome-associated coronavirus disease-2 2019 (SARS-CoV-2; COVID-19) emerged in Wuhan, Hubei Province, China (1) . The virus was subsequently identified as a coronavirus (CoV), in addition to SARS-CoV-1 and Middle East respiratory syndrome CoV (MERS-CoV) that passed from animals to humans where it can cause severe respiratory illness (2) . As of March 2020, COVID-19 has spread around the world with the WHO declaring a global pandemic (3) . Given the extent of the COVID-19 pandemic, there is an urgent need to identify potential treatments for the disease as well as to develop a vaccine.

    Search related documents:
    Co phrase search for related documents